交易中 11-18 10:57:19 美东时间
+0.040
+1.03%
PepGen reports positive Phase 2 results for PGN-EDODM1 in DM1, showing record splicing correction and notable functional improvements.
11-11 02:47
U.S. stocks fell Tuesday, led by tech; Dow dropped 300+ points. TransDigm beat estimates, while PepGen surged 142% and Microvast plunged 64%.
11-11 01:05
https://www.sec.gov/Archives/edgar/data/1835597/000119312526228960/d132482ds3.htm
05-20 00:09
US stocks rise on Tuesday, with NASDAQ up 2% and Dow up 1.37%. Communication services shares gain 2.2%, while utilities fall 0.7%. FactSet reports upbeat Q2 results and raises outlook.
04-01 00:07
US stocks higher, Dow up 0.90%, Nasdaq up 1.61%. Communication services gained 1.8%, utilities fell 0.6%. TD Synnex beats earnings estimates.
03-31 21:42
PepGen stock drops after Phase 2 low-dose data show limited splicing correction; higher-dose cohorts and FDA hold remain key focus areas.
03-31 19:14
PepGen (PEPG) shifts focus to DM1 but faces a fresh FDA roadblock. Clinical data, analyst ratings, and technical support levels inside.
03-05 17:30